Germain GS - Search Results

1

The influence of recombinant human insulin-like growth factor-I (rhIGF-I) on cell growth and cytotoxicity of drugs in childhood rhabdomyosarcoma cell lines and xenograft models.

Gidding CE, Germain GS, Dilling MB, Meeuwsen-de Boer TG, Ashmun RA, de Graaf SS, Veverka KA, Kamps WA, Houghton PJ. Gidding CE, et al. Among authors: germain gs. Cancer Chemother Pharmacol. 2000;45(1):21-30. doi: 10.1007/PL00006738. Cancer Chemother Pharmacol. 2000. PMID: 10647497

2

Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor.

Dilling MB, Dias P, Shapiro DN, Germain GS, Johnson RK, Houghton PJ. Dilling MB, et al. Among authors: germain gs. Cancer Res. 1994 Feb 15;54(4):903-7. Cancer Res. 1994. PMID: 7508822

3

Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells.

Hosoi H, Dilling MB, Shikata T, Liu LN, Shu L, Ashmun RA, Germain GS, Abraham RT, Houghton PJ. Hosoi H, et al. Among authors: germain gs. Cancer Res. 1999 Feb 15;59(4):886-94. Cancer Res. 1999. PMID: 10029080

4

Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.

Thimmaiah KN, Easton J, Huang S, Veverka KA, Germain GS, Harwood FC, Houghton PJ. Thimmaiah KN, et al. Among authors: germain gs. Cancer Res. 2003 Jan 15;63(2):364-74. Cancer Res. 2003. PMID: 12543789

5

Cellular pharmacology of 5-fluorouracil in a human colon adenocarcinoma cell line selected for thymidine kinase deficiency.

Radparvar S, Houghton PJ, Germain G, Pennington J, Rahman A, Houghton JA. Radparvar S, et al. Biochem Pharmacol. 1990 Jun 1;39(11):1759-65. doi: 10.1016/0006-2952(90)90122-2. Biochem Pharmacol. 1990. PMID: 2344373

6

Morphological and molecular characterization of spontaneous myogenic differentiation in a human rhabdomyosarcoma cell line.

Shapiro DN, Houghton PJ, Hazelton BJ, Germain GS, Murti KG, Rahman A, Houghton JA. Shapiro DN, et al. Among authors: germain gs. Cancer Res. 1990 Sep 15;50(18):6002-9. Cancer Res. 1990. PMID: 2203524

7

N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea, a novel agent equally cytotoxic to nonproliferating human colon adenocarcinoma cells.

Houghton PJ, Bailey FC, Germain GS, Grindey GB, Witt BC, Houghton JA. Houghton PJ, et al. Among authors: germain gs. Cancer Res. 1990 Jan 15;50(2):318-22. Cancer Res. 1990. PMID: 2295071

8

Proliferation-dependent and -independent cytotoxicity by antitumor diarylsulfonylureas. Indication of multiple mechanisms of drug action.

Sosinski J, Thakar JH, Germain GS, Harwood FC, Houghton PJ. Sosinski J, et al. Among authors: germain gs. Biochem Pharmacol. 1993 May 25;45(10):2135-42. doi: 10.1016/0006-2952(93)90027-t. Biochem Pharmacol. 1993. PMID: 8512595

9

Phytic acid stimulates the growth of a human rhabdomyosarcoma.

Germain GS, Houghton PJ. Germain GS, et al. In Vitro Cell Dev Biol Anim. 1997 Sep;33(8):581-3. doi: 10.1007/s11626-997-0102-6. In Vitro Cell Dev Biol Anim. 1997. PMID: 9338134 No abstract available.

10

4E-binding proteins, the suppressors of eukaryotic initiation factor 4E, are down-regulated in cells with acquired or intrinsic resistance to rapamycin.

Dilling MB, Germain GS, Dudkin L, Jayaraman AL, Zhang X, Harwood FC, Houghton PJ. Dilling MB, et al. Among authors: germain gs. J Biol Chem. 2002 Apr 19;277(16):13907-17. doi: 10.1074/jbc.M110782200. Epub 2002 Feb 14. J Biol Chem. 2002. PMID: 11847216 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters